Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:KDNY

Chinook Therapeutics (KDNY) Stock Price, News & Analysis

Chinook Therapeutics logo

About Chinook Therapeutics Stock (NASDAQ:KDNY)

Advanced Chart

Key Stats

Today's Range
$40.39
$40.39
50-Day Range
$38.66
$40.39
52-Week Range
$18.34
$40.51
Volume
N/A
Average Volume
1.19 million shs
Market Capitalization
$2.90 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive KDNY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chinook Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

KDNY Stock News Headlines

Three Finalists Announced for the 2024 Bloom Burton Award
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
Chinook Elementary
Chinook Therapeutics, Inc. (KDNY)
Expert Ratings for Chinook Therapeutics
See More Headlines

KDNY Stock Analysis - Frequently Asked Questions

Chinook Therapeutics, Inc. (NASDAQ:KDNY) released its quarterly earnings data on Tuesday, May, 9th. The company reported ($0.85) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.82) by $0.03. The company's quarterly revenue was down 32.2% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that Chinook Therapeutics investors own include Advanced Micro Devices (AMD), Meta Platforms (META), NIO (NIO), Ovintiv (OVV), Plug Power (PLUG), AMC Entertainment (AMC) and Applied Materials (AMAT).

Company Calendar

Last Earnings
5/09/2023
Today
7/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:KDNY
CIK
1435049
Fax
N/A
Employees
214
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($3.52)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$187.87 million
Net Margins
-4,199.93%
Pretax Margin
-4,115.56%
Return on Equity
-58.28%
Return on Assets
-44.72%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.82
Quick Ratio
5.82

Sales & Book Value

Annual Sales
$6.13 million
Price / Sales
473.15
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.91 per share
Price / Book
5.85

Miscellaneous

Outstanding Shares
71,810,000
Free Float
59,749,000
Market Cap
$2.90 billion
Optionable
Optionable
Beta
0.34
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:KDNY) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners